HARROW INC (HROW) Fundamental Analysis & Valuation

NASDAQ:HROW • US4158581094

38.605 USD
-14.99 (-27.96%)
At close: Mar 3, 2026
39.78 USD
+1.18 (+3.04%)
Pre-Market: 3/4/2026, 8:04:14 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This HROW fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

HROW gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. HROW has an average financial health and profitability rating. HROW has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. HROW Profitability Analysis

1.1 Basic Checks

  • HROW had positive earnings in the past year.
  • In the past year HROW had a positive cash flow from operations.
  • In the past 5 years HROW always reported negative net income.
  • In multiple years HROW reported negative operating cash flow during the last 5 years.
HROW Yearly Net Income VS EBIT VS OCF VS FCFHROW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

  • HROW's Return On Assets of -1.37% is fine compared to the rest of the industry. HROW outperforms 76.68% of its industry peers.
  • The Return On Equity of HROW (-10.60%) is better than 74.61% of its industry peers.
  • HROW has a better Return On Invested Capital (7.48%) than 86.01% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HROW is significantly below the industry average of 12.91%.
  • The last Return On Invested Capital (7.48%) for HROW is above the 3 year average (1.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.37%
ROE -10.6%
ROIC 7.48%
ROA(3y)-7.09%
ROA(5y)-9.18%
ROE(3y)-36.88%
ROE(5y)-57.31%
ROIC(3y)1.25%
ROIC(5y)1.34%
HROW Yearly ROA, ROE, ROICHROW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

  • HROW has a better Operating Margin (11.27%) than 84.46% of its industry peers.
  • HROW's Operating Margin has improved in the last couple of years.
  • HROW has a Gross Margin of 74.56%. This is amongst the best in the industry. HROW outperforms 81.35% of its industry peers.
  • HROW's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.27%
PM (TTM) N/A
GM 74.56%
OM growth 3Y20.78%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5Y2.29%
HROW Yearly Profit, Operating, Gross MarginsHROW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. HROW Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HROW is destroying value.
  • HROW has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HROW Yearly Shares OutstandingHROW Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
HROW Yearly Total Debt VS Total AssetsHROW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • HROW has an Altman-Z score of 3.40. This indicates that HROW is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.40, HROW is doing good in the industry, outperforming 69.95% of the companies in the same industry.
  • HROW has a Debt/Equity ratio of 5.17. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 5.17, HROW is not doing good in the industry: 80.83% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 5.17
Debt/FCF N/A
Altman-Z 3.4
ROIC/WACC0.78
WACC9.54%
HROW Yearly LT Debt VS Equity VS FCFHROW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 2.72 indicates that HROW has no problem at all paying its short term obligations.
  • With a Current ratio value of 2.72, HROW perfoms like the industry average, outperforming 48.19% of the companies in the same industry.
  • HROW has a Quick Ratio of 2.52. This indicates that HROW is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.52, HROW is in line with its industry, outperforming 52.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 2.52
HROW Yearly Current Assets VS Current LiabilitesHROW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. HROW Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 125.00% over the past year.
EPS 1Y (TTM)125%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.31%

3.2 Future

  • The Earnings Per Share is expected to grow by 125.08% on average over the next years. This is a very strong growth
  • HROW is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.73% yearly.
EPS Next Y1158.77%
EPS Next 2Y416.55%
EPS Next 3Y258.53%
EPS Next 5Y125.08%
Revenue Next Year42.18%
Revenue Next 2Y41.44%
Revenue Next 3Y38.66%
Revenue Next 5Y33.73%

3.3 Evolution

HROW Yearly Revenue VS EstimatesHROW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
HROW Yearly EPS VS EstimatesHROW Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

4

4. HROW Valuation Analysis

4.1 Price/Earnings Ratio

  • HROW is valuated quite expensively with a Price/Earnings ratio of 350.95.
  • Based on the Price/Earnings ratio, HROW is valued a bit cheaper than 76.17% of the companies in the same industry.
  • HROW is valuated expensively when we compare the Price/Earnings ratio to 26.83, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 27.88, which means the current valuation is very expensive for HROW.
  • Based on the Price/Forward Earnings ratio, HROW is valued a bit cheaper than 74.09% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.95, HROW is valued at the same level.
Industry RankSector Rank
PE 350.95
Fwd PE 27.88
HROW Price Earnings VS Forward Price EarningsHROW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HROW is valued a bit cheaper than the industry average as 78.76% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.12
HROW Per share dataHROW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • HROW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HROW has a very decent profitability rating, which may justify a higher PE ratio.
  • HROW's earnings are expected to grow with 258.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y416.55%
EPS Next 3Y258.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HROW Dividend Analysis

5.1 Amount

  • No dividends for HROW!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HROW Fundamentals: All Metrics, Ratios and Statistics

HARROW INC

NASDAQ:HROW (3/3/2026, 8:17:23 PM)

Premarket: 39.78 +1.18 (+3.04%)

38.605

-14.99 (-27.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-02
Earnings (Next)05-06
Inst Owners58.38%
Inst Owner Change5.3%
Ins Owners14.8%
Ins Owner Change2.47%
Market Cap1.43B
Revenue(TTM)N/A
Net Income(TTM)-4.99M
Analysts85.71
Price Target72.13 (86.84%)
Short Float %18.43%
Short Ratio10.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)819.91%
Min EPS beat(2)-18.12%
Max EPS beat(2)1657.94%
EPS beat(4)2
Avg EPS beat(4)222.09%
Min EPS beat(4)-970.3%
Max EPS beat(4)1657.94%
EPS beat(8)3
Avg EPS beat(8)30%
EPS beat(12)4
Avg EPS beat(12)-52.89%
EPS beat(16)5
Avg EPS beat(16)-847.87%
Revenue beat(2)0
Avg Revenue beat(2)-5.01%
Min Revenue beat(2)-5.31%
Max Revenue beat(2)-4.71%
Revenue beat(4)1
Avg Revenue beat(4)-5.43%
Min Revenue beat(4)-17.73%
Max Revenue beat(4)6.04%
Revenue beat(8)2
Avg Revenue beat(8)-3.74%
Revenue beat(12)4
Avg Revenue beat(12)-3.32%
Revenue beat(16)7
Avg Revenue beat(16)-1.63%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0.83%
EPS NQ rev (3m)-3.32%
EPS NY rev (1m)-6.43%
EPS NY rev (3m)-77.05%
Revenue NQ rev (1m)0.48%
Revenue NQ rev (3m)-0.51%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-3.54%
Valuation
Industry RankSector Rank
PE 350.95
Fwd PE 27.88
P/S 5.72
P/FCF N/A
P/OCF 80.01
P/B 30.41
P/tB N/A
EV/EBITDA 34.12
EPS(TTM)0.11
EY0.28%
EPS(NY)1.38
Fwd EY3.59%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)0.48
OCFY1.25%
SpS6.75
BVpS1.27
TBVpS-3.43
PEG (NY)0.3
PEG (5Y)N/A
Graham Number1.77
Profitability
Industry RankSector Rank
ROA -1.37%
ROE -10.6%
ROCE 9.46%
ROIC 7.48%
ROICexc 9.96%
ROICexgc 45.18%
OM 11.27%
PM (TTM) N/A
GM 74.56%
FCFM N/A
ROA(3y)-7.09%
ROA(5y)-9.18%
ROE(3y)-36.88%
ROE(5y)-57.31%
ROIC(3y)1.25%
ROIC(5y)1.34%
ROICexc(3y)2.44%
ROICexc(5y)3.09%
ROICexgc(3y)9.66%
ROICexgc(5y)8.29%
ROCE(3y)1.58%
ROCE(5y)1.69%
ROICexgc growth 3Y16.24%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.77%
ROICexc growth 5YN/A
OM growth 3Y20.78%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5Y2.29%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 5.17
Debt/FCF N/A
Debt/EBITDA 5.18
Cap/Depr 207.09%
Cap/Sales 15.46%
Interest Coverage 1.19
Cash Conversion 38.15%
Profit Quality N/A
Current Ratio 2.72
Quick Ratio 2.52
Altman-Z 3.4
F-Score7
WACC9.54%
ROIC/WACC0.78
Cap/Depr(3y)560.55%
Cap/Depr(5y)363.77%
Cap/Sales(3y)46.48%
Cap/Sales(5y)28.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
EPS Next Y1158.77%
EPS Next 2Y416.55%
EPS Next 3Y258.53%
EPS Next 5Y125.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.31%
Revenue Next Year42.18%
Revenue Next 2Y41.44%
Revenue Next 3Y38.66%
Revenue Next 5Y33.73%
EBIT growth 1Y428.64%
EBIT growth 3Y69.3%
EBIT growth 5YN/A
EBIT Next Year1299.14%
EBIT Next 3Y241.92%
EBIT Next 5Y132.11%
FCF growth 1Y87.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y308.55%
OCF growth 3YN/A
OCF growth 5YN/A

HARROW INC / HROW FAQ

Can you provide the ChartMill fundamental rating for HARROW INC?

ChartMill assigns a fundamental rating of 4 / 10 to HROW.


Can you provide the valuation status for HARROW INC?

ChartMill assigns a valuation rating of 4 / 10 to HARROW INC (HROW). This can be considered as Fairly Valued.


Can you provide the profitability details for HARROW INC?

HARROW INC (HROW) has a profitability rating of 6 / 10.


How financially healthy is HARROW INC?

The financial health rating of HARROW INC (HROW) is 4 / 10.


What is the expected EPS growth for HARROW INC (HROW) stock?

The Earnings per Share (EPS) of HARROW INC (HROW) is expected to grow by 1158.77% in the next year.